Shire competitorsClear all

Shire's top competitors include Alexion Pharmaceuticals, Regeneron Pharmaceuticals, Vertex Pharmaceuticals, Biogen, Gilead Sciences, Amgen and Sanofi Genzyme.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Shire
Shire
Shire is a specialty biopharmaceutical company.
Alexion Pharmaceuticals
Alexion Pharmaceuticals
Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines.
Vertex Pharmaceuticals
Vertex Pharmaceuticals
Vertex Pharmaceuticals is a biotechnology company that invests in scientific innovation to create medicines for people with cystic fibrosis.
Biogen
Biogen
Biogen is a biopharmaceutical company that discovers, develops, and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.
Gilead Sciences
Gilead Sciences
Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines.
Amgen
Amgen
Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products.
Sanofi Genzyme
Sanofi Genzyme
Sanofi Genzyme (also known as Genzyme Corporation) is a biotech company that specializes in rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology.
Founding Date
Founding Date
1986
Founding Date
1992
Founding Date
1988
Founding Date
1989
Founding Date
1978
Founding Date
1987
Founding Date
1980
Founding Date
1981
Type
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Dublin, IE HQ
The Rocks, AU
Wien, AT
Bruxelles, BE
Sofia, BG
see more
Locations
Boston, US HQ
Frenchs Forest, AU
Elsene, BE
São Paulo, BR
Vaughan, CA
Shanghai, CN
Bogotá, CO
see more
Locations
Tarrytown, US HQ
Dublin, IE
Limerick, IE
Uxbridge, GB
Bernards, US
Rensselaer, US
Sleepy Hollow, US
see more
Locations
Boston, US HQ
St Leonards, AU
Wien, AT
Toronto, CA
see more
Locations
Cambridge, US HQ
Vicente López, AR
Macquarie Park, AU
Wien, AT
Machelen, BE
Mississauga, CA
Las Condes, CL
see more
Locations
Foster City, US HQ
Buenos Aires, AR
Melbourne, AU
Wien, AT
Machelen, BE
São Paulo, BR
Edmonton, CA
see more
Locations
Thousand Oaks, US HQ
Hydra, DZ
Vicente López, AR
Kew, AU
North Ryde, AU
Wien, AT
Machelen, BE
see more
Locations
Cambridge, US HQ
Macquarie Park, AU
Malaga, AU
Virginia, AU
São Paulo, BR
Mississauga, CA
Toronto, CA
see more
Employees
Employees
7,80441% increase
Employees
3,08216% increase
Employees
9,12313% increase
Employees
3,40013% increase
Employees
7,4005% decrease
Employees
13,60015% increase
Employees
24,3004% increase
Employees
10,077
Valuation ($)
Valuation ($)
N/A
Valuation ($)
40.3 b
Valuation ($)
69.5 b
Valuation ($)
48.9 b
Valuation ($)
45 b
Valuation ($)
90 b
Valuation ($)
125.3 b
Valuation ($)
N/A
Twitter followers
Twitter followers
7.7 k
Twitter followers
12.8 k
Twitter followers
30 k
Twitter followers
66.7 k
Twitter followers
40.8 k
Twitter followers
68.6 k
Twitter followers
101.4 k
Twitter followers
59.2 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
11
Number of tweets (last 30 days)
20
Number of tweets (last 30 days)
4
Number of tweets (last 30 days)
17
Number of tweets (last 30 days)
8
Number of tweets (last 30 days)
100
Number of tweets (last 30 days)
7
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
2.8
Average likes per tweet (last 30 days)
21.1
Average likes per tweet (last 30 days)
8
Average likes per tweet (last 30 days)
11.4
Average likes per tweet (last 30 days)
13.3
Average likes per tweet (last 30 days)
11.8
Average likes per tweet (last 30 days)
9.7
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
90.91%
Percentage of tweets with engagement (last 30 days)
90%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
85.71%
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
225347
Alexa Website Rank
183060
Alexa Website Rank
109138
Alexa Website Rank
246864
Alexa Website Rank
138959
Alexa Website Rank
149411
Alexa Website Rank
320983
Employee Rating
Employee Rating
3
Employee Rating
3.9
Employee Rating
3.9
Employee Rating
3.7
Employee Rating
4.1
Employee Rating
3.8
Employee Rating
4.1
Employee Rating
N/A

Financial

Revenue (est.)
Revenue (est.)
£43m (FY, 2018)
Revenue (est.)
$6.1b (FY, 2020)
Revenue (est.)
$8.5b (FY, 2020)
Revenue (est.)
$6.2b (FY, 2020)
Revenue (est.)
$13.4b (FY, 2020)
Revenue (est.)
$24.7b (FY, 2020)
Revenue (est.)
$25.4b (FY, 2020)
Revenue (est.)
€10.4b (FY, 2019)
Cost of goods
Cost of goods
N/A
Cost of goods
$553.5m (FY, 2020)
Cost of goods
$1.1b (FY, 2020)
Cost of goods
$736.3m (FY, 2020)
Cost of goods
$1.8b (FY, 2020)
Cost of goods
$4.6b (FY, 2020)
Cost of goods
$6.2b (FY, 2020)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$5.5b (FY, 2020)
Gross profit
$7.4b (FY, 2020)
Gross profit
$5.5b (FY, 2020)
Gross profit
$11.6b (FY, 2020)
Gross profit
$20.1b (FY, 2020)
Gross profit
$19.3b (FY, 2020)
Gross profit
N/A
Net income
Net income
£3.4m (FY, 2018)
Net income
$603.4m (FY, 2020)
Net income
$3.5b (FY, 2020)
Net income
$2.7b (FY, 2020)
Net income
$4.1b (FY, 2020)
Net income
$89m (FY, 2020)
Net income
$7.3b (FY, 2020)
Net income
N/A

Operating

Countries
Countries
100 (FY, 2017)
Countries
N/A
Countries
N/A
Countries
N/A
Countries
N/A
Countries
35 (FY, 2020)
Countries
100 (FY, 2020)
Countries
100 (Nov, 2020)
Patent Applications (US)
Patent Applications (US)
N/A
Patent Applications (US)
N/A
Patent Applications (US)
N/A
Patent Applications (US)
N/A
Patent Applications (US)
N/A
Patent Applications (US)
394 (Dec, 2020)
Patent Applications (US)
N/A
Patent Applications (US)
376 (Nov, 2020)
Patents (EU)
Patents (EU)
N/A
Patents (EU)
N/A
Patents (EU)
17 (FY, 2020)
Patents (EU)
N/A
Patents (EU)
N/A
Patents (EU)
N/A
Patents (EU)
21 (FY, 2020)
Patents (EU)
N/A
Patents (US)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
31 (FY, 2020)
Patents (US)
N/A
Patents (US)
21 (FY, 2019)
Patents (US)
650 (Dec, 2020)
Patents (US)
31 (FY, 2020)
Patents (US)
605 (Nov, 2020)
Phase I Trials Products
Phase I Trials Products
7 (FY, 2017)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
13 (Q3, 2020)
Phase I Trials Products
N/A
Phase I Trials Products
20 (FY, 2020)
Phase I Trials Products
N/A
Phase II Trials Products
Phase II Trials Products
10 (FY, 2017)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
9 (Q3, 2020)
Phase II Trials Products
N/A
Phase II Trials Products
5 (FY, 2020)
Phase II Trials Products
N/A
Phase III Trials Products
Phase III Trials Products
15 (FY, 2017)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
6 (Q3, 2020)
Phase III Trials Products
8 (FY, 2020)
Phase III Trials Products
11 (FY, 2020)
Phase III Trials Products
N/A
Products
Products
N/A
Products
5 (Q1, 2021)
Products
7 (FY, 2020)
Products
6 (FY, 2020)
Products
N/A
Products
20 (FY, 2020)
Products
N/A
Products
25 (Nov, 2020)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 8.9m
Total funding raised
$ 2.4m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Alexion Pharmaceuticals
HQ
Boston, US
Employees
3,082↑ 16% increase

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases.

View company
Regeneron Pharmaceuticals
HQ
Tarrytown, US
Employees
9,123↑ 13% increase

Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines.

View company
Vertex Pharmaceuticals
HQ
Boston, US
Employees
3,400↑ 13% increase

Vertex Pharmaceuticals is a biotechnology company that invests in scientific innovation to create medicines for people with cystic fibrosis.

View company
Biogen
HQ
Cambridge, US
Employees
7,400↓ 5% decrease

Biogen is a biopharmaceutical company that discovers, develops, and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.

View company